Oviva Therapeutics is a biotechnology company driving forward R&D in women's health and ovarian physiology with an aim to improve healthspan in women. They are currently in advanced preclinical stage for a therapeutic targeting protection of the ovarian reserve and extension of ovarian function.


Biotechnology

Research

Oviva Therapeutics

Daisy Robinton

Rachel Rubin

The leadership team at Oviva Therapeutics has a history of working in women's health, genetic engineering, medicine, agriculture, and law. They have also been a guest lecturer at UCLA and have worked as a postdoctoral fellow, associate professor, and associate director at Boston Children's Hospital, Harvard Medical School, and the Massachusetts General Hospital.

Leadership Team

About

Team members

Other teams at Oviva Therapeutics

Board of Directors

Founding Team